Clinical Focus ›› 2023, Vol. 38 ›› Issue (3): 285-288.doi: 10.3969/j.issn.1004-583X.2023.03.017
-
Received:2022-11-27Online:2023-03-20Published:2023-05-11
CLC Number:
Cite this article
share this article
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2023.03.017
| [1] | 钱易, 马翔. 多囊卵巢综合征诊断标准解读[J]. 中国实用妇科与产科杂志, 2019, 35(3):264-267. |
| [2] |
Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun, 1998, 251(2):471-476.
doi: 10.1006/bbrc.1998.9489 URL |
| [3] | Ranjbar Kohan N, Tabandeh MR, Nazifi S, et al. L-carnitine improves metabolic disorders and regulates Apelin and Apelin receptor genes expression in adipose tissue in diabetic rats[J]. Physiol Rep, 2020, 8(23):e14641. |
| [4] |
Liu J, Liu M, Chen L. Novel pathogenesis: Regulation of apoptosis by Apelin/APJ system[J]. Acta Biochim Biophys Sin (Shanghai), 2017, 49(6):471-478.
doi: 10.1093/abbs/gmx035 URL |
| [5] |
Castan-Laurell I, Masri B, Valet P. The Apelin/APJ system as a therapeutic target in metabolic diseases[J]. Expert Opin Ther Targets, 2019, 23(3):215-225.
doi: 10.1080/14728222.2019.1561871 URL |
| [6] |
Sörhede Winzell M, Magnusson C, Ahrén B. The APJ receptor is expressed in pancreatic islets and its ligand, Apelin, inhibits insulin secretion in mice[J]. Regul Pept, 2005, 131(1-3):12-17.
doi: 10.1016/j.regpep.2005.05.004 URL |
| [7] | Palmer ES, Irwin N, O'Harte FP. Potential therapeutic role for Apelin and related peptides in diabetes: An update[J]. Clin Med Insights Endocrinol Diabetes, 2022, 15:11795514221074679. |
| [8] |
Marousez L, Hanssens S, Butruille L, et al. Breast milk apelin level increases with maternal obesity and high-fat feeding during lactation[J]. Int J Obes (Lond), 2021, 45(5):1052-1060.
doi: 10.1038/s41366-021-00772-y |
| [9] |
Yin C, Zhang H, Zhang M, et al. Adropin and Apelin-12 efficiently predict metabolic syndrome in obese children[J]. Pediatr Diabetes, 2020, 21(7):1132-1139.
doi: 10.1111/pedi.v21.7 URL |
| [10] |
Gourgue F, Mignion L, Van Hul M, et al. Obesity and triple-negative-breast-cancer: Is Apelin a new key target?[J]. J Cell Mol Med, 2020, 24(17):10233-10244.
doi: 10.1111/jcmm.v24.17 URL |
| [11] |
Bertrand C, Pradère JP, Geoffre N, et al. Chronic Apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism[J]. Endocrine, 2018, 60(1):112-121.
doi: 10.1007/s12020-018-1536-1 pmid: 29392617 |
| [12] |
Yasir M, Senthilkumar GP, Jayashree K, et al. Association of serum omentin-1, Apelin and chemerin concentrations with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus patients[J]. Arch Physiol Biochem, 2022, 128(2):313-320.
doi: 10.1080/13813455.2019.1680698 URL |
| [13] |
Griffiths PR, Lolait SJ, Paton JFR, et al. Circumventricular organ Apelin receptor knockdown decreases blood pressure and sympathetic drive responses in the spontaneously hypertensive rat[J]. Front Physiol, 2021, 12:711041.
doi: 10.3389/fphys.2021.711041 URL |
| [14] |
Yuan Y, Wang W, Zhang Y, et al. Apelin-13 attenuates lipopolysaccharide-induced inflammatory responses and acute lung injury by regulating PFKFB3-driven glycolysis induced by NOX4-dependent ROS[J]. J Inflamm Res, 2022, 15:2121-2139.
doi: 10.2147/JIR.S348850 pmid: 35386222 |
| [15] | Gören K, Saˇgsöz N, Noyan V, et al. Plasma Apelin levels in patients with polycystic ovary syndrome[J]. J Turk Ger Gynecol Assoc, 2012, 13(1):27-31. |
| [16] | 彭丽敏, 韩丽荣, 焦玉梅. 多囊卵巢综合征不孕患者肠道菌群与血清性激素及脂肪因子关系[J]. 中国计划生育学杂志, 2022, 30(7):1612-1616. |
| [17] | 蔡玉, 刁海丹. 血清TGF-β1、Apelin、CYP19A1水平与PCOS内分泌异常间的关系分析[J]. 生殖医学杂志, 2022, 31(4):463-467. |
| [18] |
Sun X, Wu X, Zhou Y, et al. Evaluation of Apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinylestradiol plus metformin[J]. Med Sci Monit, 2015, 21:2547-2552.
doi: 10.12659/MSM.894926 URL |
| [19] | 张全. 多囊卵巢综合征不孕患者血清CTRP3、chemerin、Apelin 变化及临床意义[J]. 中国计划生育学杂志, 2020, 28(2):184-188. |
| [20] |
Altinkaya SÖ, Nergiz S, Küçük M, et al. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 176:168-172.
doi: 10.1016/j.ejogrb.2014.02.022 pmid: 24642195 |
| [21] |
Kolan Ska-Dams E, Boinska J, Socha MW. Adipokine levels and carbohydrate metabolism in patients diagnosed de novo with polycystic ovary syndrome[J]. Qatar Med J, 2021, 2021(2):34.
doi: 10.5339/qmj.2021.34 pmid: 34604014 |
| [22] |
Gao Y, Xin C, Fan H, et al. Circulating Apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis[J]. Front Endocrinol (Lausanne), 2023, 13:1076951.
doi: 10.3389/fendo.2022.1076951 URL |
| [23] | 褚冉, 梁毓. 多囊卵巢综合征患者血清脂肪因子Asprosin、Apelin-13表达及与胰岛素抵抗关系[J]. 中国计划生育学杂志, 2022, 30(4):846-850. |
| [24] |
OŻegowska K, Bartkowiak-Wieczorek J, Bogacz A, et al. Relationship between adipocytokines and angiotensin converting enzyme gene insertion/deletion polymorphism in lean women with and without polycystic ovary syndrome[J]. Gynecol Endocrinol, 2020, 36(6):496-500.
doi: 10.1080/09513590.2019.1695248 pmid: 31814467 |
| [25] | 杜静, 张二红, 廖月婵, 等. 多囊卵巢综合征患者血清Apelin水平与激素、代谢异常的关系[J]. 中国妇幼保健, 2018, 33(05):1048-1050. |
| [26] |
Jena D, Choudhury AK, Mangaraj S, et al. Study of visceral and subcutaneous abdominal fat thickness and its correlation with cardiometabolic risk factors and hormonal parameters in polycystic ovary syndrome[J]. Indian J Endocrinol Metab, 2018, 22(3):321-327.
doi: 10.4103/ijem.IJEM_646_17 pmid: 30090722 |
| [27] |
Lazúrová I, Lazúrová Z, Figurová J, et al. Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome[J]. Physiol Res, 2019, 68(3):457-465.
pmid: 30904012 |
| [28] |
Hallajzadeh J, Khoramdad M, Karamzad N, et al. Metabolic syndrome and its components among women with polycystic ovary syndrome: A systematic review and meta-analysis[J]. J Cardiovasc Thorac Res, 2018, 10(2):56-69.
doi: 10.15171/jcvtr.2018.10 pmid: 30116503 |
| [29] |
Podgórska M, Pietraszek-Gremplewicz K, Olszańska J, et al. The role of Apelin and Apelin receptor expression in migration and invasiveness of colon cancer cells[J]. Anticancer Res, 2021, 41(1):151-161.
doi: 10.21873/anticanres.14760 pmid: 33419808 |
| [30] |
Uribesalgo I, Hoffmann D, Zhang Y, et al. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy[J]. EMBO Mol Med, 2019, 11(8):e9266.
doi: 10.15252/emmm.201809266 |
| [31] |
Cekmez F, Cekmez Y, Pirgon O, et al. Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome[J]. Eur Cytokine Netw, 2011, 22(1):32-37.
doi: 10.1684/ecn.2011.0279 pmid: 21411410 |
| [32] | 刘淼, 付丹, 王丹, 等. 多囊卵巢综合征不孕患者血清CTRP3、趋化素及Apelin水平变化意义探讨[J]. 临床和实验医学杂志, 2021, 20(24):2634-2637. |
| [1] | Guo Qian, Chen Jie, Ma Weirong, Zhang Yan, Yang Yingqian, Tan Yong. Bioinformatics-driven investigation into the molecular pathways of polycystic ovary syndrome [J]. Clinical Focus, 2025, 40(7): 608-618. |
| [2] | Ren Yumei, Zhang Qiu, Hu Honglin. Effect of serum s100A4 levels on polycystic ovary syndrome in patients with polycystic ovary syndrome [J]. Clinical Focus, 2023, 38(12): 1078-1085. |
| [3] | Li Lei, Aaletengqiqige, Zhang Mingchen, Jiang Sheng. Meta-analysis on efficacy and safety of glucagon like peptide-1 receptor agonist on patients with polycystic ovary syndrome [J]. Clinical Focus, 2021, 36(5): 395-401. |
| [4] | Xiang Shoukui;Wang Long;Wu Yang;Qian Fengjuan;Jiang Xiaohong;Hua Fei. Association between serum vitamin D and depression in women with polycystic ovarian syndrome [J]. Clinical Focus, 2015, 30(6): 649-652653. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||